Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Preceptrol®
no
Type Strain
yes
(type strain)
Comments
Oxidative conversion of 3-keto-nuclear-saturated steroids to corresponding delta 1,4-steroids compounds
Colonial development
Medium
ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor
Chas. Pfizer & Co., Inc.
References
Shull GM. Preparation of 3-keto-delta1,4-steroids from 3-keto-delta4-steroids with Micromonospora. US Patent 2,809,919 dated Oct 15 1957
Shull GM. Preparation of delta1,4 steroid compounds by Micromonospora. US Patent 2,890,153 dated Jun 9 1959
Luedemann GM. Designation of neotype strains for Micromonospora coerulea Jensen 1932 and Micromonospora chalcea (Foulerton 1905) Orskov 1923. Int. J. Syst. Bacteriol. 21: 248-253, 1971.
Suarez JE, Hardisson C. Morphological characteristics of colony development in Micromonospora chalcea. J. Bacteriol. 162: 1342-1344, 1985. PubMed: 3997781
Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980.
